{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:34:36Z","timestamp":1792571676389,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,11,27]],"date-time":"2004-11-27T00:00:00Z","timestamp":1101513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00280-004-0870-6","type":"journal-article","created":{"date-parts":[[2004,11,26]],"date-time":"2004-11-26T15:25:49Z","timestamp":1101482749000},"page":"203-212","source":"Crossref","is-referenced-by-count":10,"title":["Control of Atm?\/? thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone"],"prefix":"10.1007","volume":"55","author":[{"given":"Xianghong","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia L.","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenan","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Williams S.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K. Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,27]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.immunol.15.1.177","volume":"15","author":"MF Lavin","year":"1997","unstructured":"Lavin MF, Shiloh Y (1997) The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 15:177?202","journal-title":"Annu Rev Immunol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jnci\/92.10.795","volume":"92","author":"KK Khanna","year":"2000","unstructured":"Khanna KK (2000) Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst 92:795?802","journal-title":"J Natl Cancer Inst"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","volume":"87","author":"AM Taylor","year":"1996","unstructured":"Taylor AM, Metcalfe JA, Thick J, Mak YF (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423?438","journal-title":"Blood"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/1042819021000002884","volume":"43","author":"T Stankovic","year":"2002","unstructured":"Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM (2002) ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 43:1563?1571","journal-title":"Leuk Lymphoma"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jcp.54.7.512","volume":"54","author":"J Boultwood","year":"2001","unstructured":"Boultwood J (2001) Ataxia telangiectasia gene mutation in leukaemia and lymphoma. J Clin Pathol 54:512?516","journal-title":"J Clin Pathol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1182\/blood.V91.10.3920.3920_3920_3926","volume":"91","author":"D Stoppa-Lyonnet","year":"1998","unstructured":"Stoppa-Lyonnet D, Soulier J, Laquge A (1998) Inactivation of the ATM gene in T cell prolymphocytic leukemias. Blood 91:3920?3926","journal-title":"Blood"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/humu.9140","volume":"21","author":"F Gumy Pause","year":"2003","unstructured":"Gumy Pause F, Wacker P, Maillet P, Betts D, Sappino AP (2003) ATM gene alterations in childhood acute lymphoblastic leukemias. Hum Mutat 21:554","journal-title":"Hum Mutat"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","volume":"97","author":"C Schaffner","year":"2000","unstructured":"Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A 97:2773?2778","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)80086-0","volume":"86","author":"C Barlow","year":"1996","unstructured":"Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159?171","journal-title":"Cell"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1101\/gad.10.19.2411","volume":"10","author":"Y Xu","year":"1996","unstructured":"Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D (1996) Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 10:2411?2422","journal-title":"Genes Dev"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood.V96.5.1940","volume":"96","author":"M Liyanage","year":"2000","unstructured":"Liyanage M, Weaver Z, Barlow C, Coleman A, Pankratz DG, Anderson S, Wynshaw-Boris A, Ried T (2000) Abnormal rearrangement within the T-cell receptor locus in lymphomas from Atm-deficient mice. Blood 96:1940?1946","journal-title":"Blood"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1096\/fj.00-0601com","volume":"15","author":"M Yan","year":"2001","unstructured":"Yan M, Qiang W, Liu N, Shen J, Lynn WS, Wong PKY (2001) The ataxia telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. FASEB J 15:1132?1138","journal-title":"FASEB J"},{"key":"CR13","first-page":"5153","volume":"62","author":"M Yan","year":"2002","unstructured":"Yan M, Kuang X, Qiang W, Shen J, Claypool K, Lynn WS, Wong PKY (2002) Prevention of thymic lymphoma development in Atm?\/? mice by dexamethasone. Cancer Res 62:5153?5157","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004180000165","volume":"114","author":"R Kofler","year":"2000","unstructured":"Kofler R (2000) The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem Cell Biol 114:1?7","journal-title":"Histochem Cell Biol"},{"key":"CR15","first-page":"2136","volume":"47","author":"K Tanaka","year":"1987","unstructured":"Tanaka K, Koga Y, Taniguchi K, Nomoto K (1987) T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state. Cancer Res 47:2136?2141","journal-title":"Cancer Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1073\/pnas.72.5.1873","volume":"72","author":"W Liang","year":"1975","unstructured":"Liang W, Cohen EP (1975) Somatic hybrid of thymus leukemia (+) and (?) cells forms thymus leukemia antigen but fails to undergo modulation. Proc Natl Acad Sci U S A 72:1873?1877","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR17","volume-title":"Flow cytometry: a practical approach","year":"1992","unstructured":"Ormerod MG (ed) (1992) Flow cytometry: a practical approach, 2nd edn. Oxford University Press, New York","edition":"2"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1128\/JVI.73.5.3893-3903.1999","volume":"73","author":"S Asin","year":"1999","unstructured":"Asin S, Taylor JA, Trushin S, Bren G, Paya CV (1999) IKK mediates NF-?B activation in human immunodeficiency virus-infected cells. J Virol 73:3893?3903","journal-title":"J Virol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3835(99)00381-X","volume":"150","author":"B Chen","year":"2000","unstructured":"Chen B, de Witte PA (2000) Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett 150:111?117","journal-title":"Cancer Lett"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/eji.1830180405","volume":"18","author":"HR MacDonald","year":"1988","unstructured":"MacDonald HR, Budd RC, Howe RC (1988) A CD3? subset of CD4?8+ thymocytes: a rapidly cycling intermediate in the generation of CD4+8+ cells. Eur J Immunol 18:519?523","journal-title":"Eur J Immunol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.173.3.561","volume":"173","author":"T Hunig","year":"1991","unstructured":"Hunig T, Mitnacht R (1991) T cell receptor-mediated selection of functional rat CD8 T cells from defined immature thymocyte precursors in short-term suspension culture. J Exp Med 173:561?568","journal-title":"J Exp Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1073\/pnas.95.13.7351","volume":"95","author":"SN Malek","year":"1998","unstructured":"Malek SN, Dordai DI, Reim J, Dintzis H, Desiderio S (1998) Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc Natl Acad Sci U S A 95:7351?7356","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jlb.60.5.563","volume":"60","author":"WY Almawi","year":"1996","unstructured":"Almawi WY, Beyhum HN, Rahme AA, Rieder MJ (1996) Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol 60:563?572","journal-title":"J Leukoc Biol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/bbrc.2000.3922","volume":"279","author":"SL Planey","year":"2000","unstructured":"Planey SL, Litwack G (2000) Glucocorticoid-induced apoptosis in lymphocytes. Biochem Biophys Res Commun 279:307?312","journal-title":"Biochem Biophys Res Commun"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122?3133","journal-title":"Blood"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844?848","journal-title":"Science"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","volume":"87","author":"PA Baeuerle","year":"1996","unstructured":"Baeuerle PA, Baltimore D (1996) NF-?B: ten years after. Cell 87:13?20","journal-title":"Cell"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9440(10)61708-7","volume":"159","author":"F Chen","year":"2001","unstructured":"Chen F, Castranova V, Shi X (2001) New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159:387?397","journal-title":"Am J Pathol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","volume":"39","author":"DG Johnson","year":"1999","unstructured":"Johnson DG, Walker CL (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39:295?312","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/MCB.15.5.2612","volume":"15","author":"M Ohtsubo","year":"1995","unstructured":"Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612?2624","journal-title":"Mol Cell Biol"},{"key":"CR31","first-page":"1681","volume":"8","author":"S Greenstein","year":"2002","unstructured":"Greenstein S, Ghias K, Krett NL, Rosen ST (2002) Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 8:1681?1694","journal-title":"Clin Cancer Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01147-4","volume":"64","author":"A Amsterdam","year":"2002","unstructured":"Amsterdam A, Tajima K, Sasson R (2002) Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 64:843?850","journal-title":"Biochem Pharmacol"},{"key":"CR33","first-page":"2766","volume":"61","author":"ME Tome","year":"2001","unstructured":"Tome ME, Baker AF, Powis G, Payne CM, Briehl MM (2001) Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 61:2766?2773","journal-title":"Cancer Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-230X(01)83007-4","volume":"83","author":"Y Shiloh","year":"2001","unstructured":"Shiloh Y, Kastan MB (2001) ATM: gene stability, neuronal development, and cancer cross paths. Adv Cancer Res 83:209?254","journal-title":"Adv Cancer Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"15420","DOI":"10.1074\/jbc.271.26.15420","volume":"271","author":"DJ Dobbelsteen van den","year":"1996","unstructured":"van den Dobbelsteen DJ, Nobel CSI, Schlegel J, Cotgreave IA, Orrenius S, Slater AF (1996) Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas-APO-1 antibody. J Biol Chem 271:15420?15427","journal-title":"J Biol Chem"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.4049\/jimmunol.158.10.4612","volume":"158","author":"A Macho","year":"1997","unstructured":"Macho A, Hirsch T, Marzo I, Marchetti P, Dallaporta B, Susin SA, Zamzami N, Kroemer G (1997) Glutathione depletion is an early and calcium elevation is a late event of thymocytes apoptosis. J Immunol 158:4612?4619","journal-title":"J Immunol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","volume":"18","author":"JD Ashwell","year":"2000","unstructured":"Ashwell JD, Lu FWM, Vacchio MS (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18:309?345","journal-title":"Annu Rev Immunol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.71.1.9","volume":"71","author":"WY Almawi","year":"2000","unstructured":"Almawi WY, Melemedjian OK (2000) Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71:9?15","journal-title":"J Leukoc Biol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1128\/MCB.22.18.6521-6532.2002","volume":"22","author":"A Hirao","year":"2002","unstructured":"Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, Okada H, Sarkissian T, Wong JA, Sakai T (2002) Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol 22:6521?6532","journal-title":"Mol Cell Biol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"13084","DOI":"10.1073\/pnas.93.23.13084","volume":"93","author":"A Elson","year":"1996","unstructured":"Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P (1996) Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A 93:13084?13089","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0145-2126(84)90006-7","volume":"8","author":"CH Pui","year":"1984","unstructured":"Pui CH, Dahl GV, Rivera G, Murphy SB, Costlow ME (1984) The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk Res 8:579?585","journal-title":"Leuk Res"},{"key":"CR42","first-page":"2090","volume":"6","author":"DL Bellingham","year":"1992","unstructured":"Bellingham DL, Sar M, Cidlowski JA (1992) Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol 6:2090?2102","journal-title":"Mol Endocrinol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.169.4.1837","volume":"169","author":"JA Brewer","year":"2002","unstructured":"Brewer JA, Kanagawa O, Sleckman BP, Muglia LJ (2002) Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol 169:1837?1843","journal-title":"J Immunol"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/intimm\/dxg070","volume":"15","author":"N Tosa","year":"2003","unstructured":"Tosa N, Murakami M, Jia WY, Yokoyama M, Masunaga T, Iwabuchi C, Inobe M, Iwabuchi K, Miyazaki T, Onoe K, Iwata M, Uede T (2003) Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol 15:741?749","journal-title":"Int Immunol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.4049\/jimmunol.170.5.2469","volume":"170","author":"N Tonomura","year":"2003","unstructured":"Tonomura N, McLaughlin K, Grimm L, Goldsby RA, Osborne BA (2003) Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol 170:2469?2478","journal-title":"J Immunol"},{"key":"CR46","first-page":"1849","volume":"61","author":"A Kamsler","year":"2001","unstructured":"Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, Barzilai A (2001) Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 61:1849?1854","journal-title":"Cancer Res"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/135100003125001206","volume":"8","author":"DJ Watters","year":"2003","unstructured":"Watters DJ (2003) Oxidative stress in ataxia telangiectasia. Redox Rep 8:23?29","journal-title":"Redox Rep"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/15230860260196254","volume":"4","author":"J Reichenbach","year":"2002","unstructured":"Reichenbach J, Schubert R, Schindler D, Muller K, Bohles H, Zielen S (2002) Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid Redox Signal 4:465?469","journal-title":"Antioxid Redox Signal"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1259\/0007-1285-48-569-374","volume":"48","author":"PN Cunlift","year":"1975","unstructured":"Cunlift PN, Mann JR, Cameron AH, Roberts KD, Ward HN (1975) Radiosensitivity in ataxia-telangiectasia. Br J Radiol 48:374?376","journal-title":"Br J Radiol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/08880019509029550","volume":"12","author":"M Weyl Ben Arush","year":"1995","unstructured":"Weyl Ben Arush M, Rosenthal J, Dale J, Horovitch Y, Herzl G, Ben Arie J, Ziv Y, Shiloh Y (1995) Ataxia telangiectasia and lymphoma: an indication for individualized chemotherapy dosing?report of treatment in a highly inbred Arab family. Pediatr Hematol Oncol 12:163?169","journal-title":"Pediatr Hematol Oncol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B","volume":"31","author":"C Sandoval","year":"1998","unstructured":"Sandoval C, Swift M (1998) Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol 31:491?497","journal-title":"Med Pediatr Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-004-0870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-004-0870-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-004-0870-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T13:50:50Z","timestamp":1682862650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-004-0870-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,27]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s00280-004-0870-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,27]]}}}